Overview

Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)

Status:
Completed

Trial end date:
2018-11-24

Target enrollment:

Participant gender:

Summary

This trial will study the effectiveness of photodynamic therapy with aminolaevulinic acid for the treatment of patients with HPV+ low grade cervical intraepithelial neoplasia (LSIL;CIN1).

Phase:

Phase 2

Details

Lead Sponsor:

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Treatments:

Aminolevulinic Acid